Oseltamivir Phosphate Capsule
Product Images NDC 70771-1712

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 70771-1712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 01)

30 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 01)
This is a unit-dose package of Oseltamivir Phosphate Capsules, USP. Each capsule contains oseltamivir phosphate equivalent to 30 mg oseltamivi (free base). The usual dosage recommendations and other important prescribing information can be found in the accompanying insert. The NDC for this product is 70774-1710-2. The drug is not child-resistant; therefore, it should be kept out of the reach of children. It is manufactured by Cadia Healthcare Ltd in Anmedabad, India. The dimensions of the capsules are 73mm x 22mm. The recommended storage temperature for the capsules is 25°C (77°F) with excursions permitted to 16° to 30°C (59° to 86°F) in accordance with USP Controlled Room Temperature guidelines.*
FDA Label Image

45 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 02)

45 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 02)
This is a prescription drug called Oseltamivir Phosphate, which comes in capsules of 45mg dosage. The recommended dosage is not specified and the user should check the insert for more information. The drug needs to be stored at room temperature and should be kept away from children. The unit-dose package of the drug is not child-resistant. The drug is manufactured by Cadia Healthcare Ltd. in Ahmedabad, India. The provided text does not provide any more information.*
FDA Label Image

75 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 03)

75 mg Label (2dab1ae2 Efaa 4429 8567 01e5b02de77c 03)
This text provides information about Oseltamivir Phosphate Capsules, USP which contains 75mg of oseltamivir phosphate equivalent to 75mg of oseltamivir. It consists of 10 capsules in a unit-dose package and is manufactured by Cadila Healthcare Ltd in Ahmedabad, India. The recommended storage temperature is 25°C (T7°F) and should be kept away from children. Dosage information is not provided in this text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.